In Vivo Inhibition of Nuclear Factor-κB Activation Prevents Inducible Nitric Oxide Synthase Expression and Systemic Hypotension in a Rat Model of Septic Shock

Journal of Immunology

Volumn 159, Issue 8, 1997, Pages 3976-3983

  Liu, Shu Fang ^a   Ye, Xiaobing ^a   Malik, Asrar B ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; THIOCARBAMIC ACID DERIVATIVE;

ANIMAL; ARTICLE; BIOSYNTHESIS; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYMOLOGY; HYPOTENSION; IMMUNOLOGY; MALE; METABOLISM; RAT; SEPTIC SHOCK; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; CALCIUM; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME INDUCTION; HYPOTENSION; LIPOPOLYSACCHARIDES; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; THIOCARBAMATES; TIME FACTORS;

EID: 0031572429     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Forstermann, U., E. I. Closs, J. S. Pollock, M. Nakane, P. Schwarz, I. Gath, and H. Kleinert. 1994. Nitric oxide synthase isoforms: characterization, purification, molecular cloning, and functions. Hypertension 23:1121.
2. Nathan, C., and Q. W. Xie. 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725.
3. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:109.
4. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051.
5. G-monomethyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 87:3629.
6. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172:1132.
7. MacMicking, J. D., C. Nathan, G. Horn, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. W. Xie, K. Sokol, and N. Hutchinson. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641.
8. Liu, S. F., I. M. Adcock, R. W. Old, P. J. Barnes, and T. W. Evans. 1993. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 196: 1208.
9. Stoclet, J.-C., I. Fleming, G. Gray, G. Julou-Schaeffer, F. Schneider, C. Schott, C. Schott, and J. R. Parratt. 1993. Nitric oxide and endotoxemia. Circulation 87(Suppl. 5):V77.
10. Petros, A., D. Bennett, and P. Vallance. 1991. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557.
11. Griffiths, M. J., S. F. Liu, N. P. Curzen, M. Messent, and T. W. Evans. 1995. In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery. Am. J. Physiol. 268:L509.
12. Finkel, M. S., C. V. Oddis, T. D. Jacob, S. C. Watkins, B. G. Hattler, and R. L. Simmons. 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387.
13. Parrillo, J. E. 1993. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1471.
14. Glauser, M. P., G. Zanetti, J. D. Baumgartner, and J. Cohen. 1991. Septic shock: pathogenesis. Lancet 338:732.
15. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κ B in the immune system. Annu. Rev. Immunol. 12:141.
16. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κ B. Annu. Rev. Cell Biol. 10:405.
17. Spink, J., S. Cohen, and T. J. Evans. 1995. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase: activation by nuclear factor-κ B. J. Biol. Chem. 270:29541.
18. Xie, Q., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-κ B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705.
19. Perrella, M. A., C. Patterson, L. Tan, S. F. Yet, C. M. Hsieh, M. Yoshizumi, and M. E. Lee. 1996. Suppression of interleukin-1β-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-1β in vascular smooth muscle cells: evidence for mechanisms other than NF-κB. J. Biol. Chem. 271: 13776.
20. Wong, H. R., J. D. Finder, K. Wasserloos, C. J. Lowenstein, D. A. Geller, T. R. Billiar, B. R. Pitt, and P. Davies. 1996. Transcriptional regulation of iNOS by IL-1β in cultured rat pulmonary artery smooth muscle cells. Am. J. Physiol. 271:1166.
21. Blackwell, T. S., T. R. Blackwell, E. P. Holden, B. W. Christman, and J. W. Christman. 1996. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J. Immunol. 157:1630.
22. Schreck, R., B. Meier, D. N. Mannel, W. Droge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1181.
23. Kawai, M., R. Nishikomori, E. Y. Jung, G. Tai, C. Yamanaka, M. Mayumi, and T. Heike. 1995. Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. J. Immunol. 154: 2333.
24. Ziegler-Heitbrock, H. W., T. Sternsdorf, J. Liese, B. Belohradsky, C. Weber, A. Wedel, R. Schreck, P. Bauerle, and M. Strobel. 1993. Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. J. Immunol. 151:6986.
25. Tetsuka, T., L. D. Baier, and A. R. Morrison. 1996. Antioxidants inhibit interleukin-1-induced cyclooxygenase and nitric-oxide synthase expression in rat mesangial cells: evidence for post-transcriptional regulation. J. Biol. Chem. 271: 11689.
26. Marui, N., M. K. Offermann, R. Swerlick, C. Kunsch, C. A. Rosen, M. Ahmad, R. W. Alexander, and R. M. Medford. 1993. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92:1866.
27. Munoz, C., D. Pascual-Salcedo, M. C Castellanos, A. Alfranca, J. Aragones, A. Vara, M. J. Redondo, and M. O. de Landazuri. 1996. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-κB and AP-1 transcription factors activity. Blood 88:3482.
28. Wang, W. W., C. P. Jenkinson, J. M. Griscavage, R. M. Kern, N. S. Arabolos, R. E. Byrns, S. D. Cederbaum, and L. J. Ignarro. 1995. Co-induction of arginase and nitric oxide synthase in murine macrophage activated by lipopolysaccharide. Biochem. Biophys. Res. Commun. 210:1009.
29. Ikejima, K., Y. Iimuro, D. T. Forman, and R. G. Thurman. 1996. A diet containing glycine improves survival in endotoxin shock in the rat. Am. J. Physiol. 271:G97.
30. Rose, C. E., Jr., C. A. Juliano, D. E. Tracey, T. Yoshimura, and S. M. Fu. 1994. Role of interleukin-1 in endotoxin-induced lung injury in the rat. J. Respir. Cell Mol. Biol. 10:214.
31. 15N]nitrate in biological fluids. Anal. Biochem. 126:131.
32. Xie, Q., H. J. Cho, J. Calaycay, R. A. Mumford, K. M. Swiderek, T. D. Lee, A. Ding, T. Troso, and C. Nathan. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225.
33. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
34. Fort, P., L. Marty, M. Piechaczyk, S. El Sabrouty, C. Dani, P. Jeanteur, and J. M. Blanchard. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1431.
35. Liu, S. F., P. J. Barnes, and T. W. Evans. 1997. Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo. Crit. Care Med. 25:512.
36. Khan, B. V., D. G. Harrison, M. T. Olbrych, R. W. Alexander, and R. M. Medford. 1996. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc. Natl. Acad. Sci. USA 93:114.
37. De Caterina, R., P. Libby, H. B. Peng, V. J. Thannickal, T. B. Rajavashisth, M. A. Gimbrone, Jr., W. S. Shin, and J. K. Liao. 1995. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60.
38. Kubes, P., M. Suzuki, and D. N. Granger. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88:4651.
39. Lopez-Belmonte, J., and B. J. Whittle. 1995. Aminoguanidine-provoked leukocyte adherence to rat mesenteric venues: role of constitutive nitric oxide synthase inhibition. Br. J. Pharmacol. 116:2710.
40. Florquin, S., Z. Amraoui, C. Dubois, J. Decuyper, and M. Goldman. 1994. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J. Exp. Med. 180:1153.
41. Hutcheson, I. R., B. J. Whittle, and N. K. Boughton-Smith. 1990. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br. J. Pharmacol. 101:815.
42. Givalois, L., J. Dornand, M. Mekaouche, M. D. Solier, A. F. Bristow, G. Ixart, P. Siaud, I. Assenmacher, and G. Barbanel. 1994. Temporal cascade of plasma level surges in ACTH, corticosterone, and cytokines in endotoxin-challenged rats. Am. J. Physiol. 267:R164.
43. Jotwani, R., Y. Tanaka, K. Watanabe, K. Tanaka-Bandoh, N. Kato, and K. Ueno. 1994. Comparison of cytokine induction by lipopolysaccharide of Bacteroides fragilis with Salmonella typhimurium in mice. Microbiol. Immunol. 38:763.